Payment overview · 2025
General Payments
$124.32
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rupen Joshi, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HUNTSVILLE, AL · NPI 1457341463
Verified facts
What the public records show
CMS Open Payments records show Rupen Joshi, M.D. received $124.32 in general payments during 2025 across 1 reported records.
Axsome Therapeutics, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $124.32 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $124.32 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $124.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 508 | 157 |
| Losartan Potassium | Losartan Potassium | 424 | 128 |
| Amlodipine Besylate | Amlodipine Besylate | 352 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 307 | 77 |
| Omeprazole | Omeprazole | 294 | 95 |
| Metoprolol Succinate | Metoprolol Succinate | 246 | 75 |
| Pantoprazole Sodium | Pantoprazole Sodium | 230 | 74 |
| Gabapentin | Gabapentin | 207 | 44 |
| Metformin Hcl | Metformin Hcl | 196 | 60 |
| Zolpidem Tartrate | Zolpidem Tartrate | 195 | 29 |
| Potassium Chloride | Potassium Chloride | 193 | 58 |
| Fluticasone Propionate | Fluticasone Propionate | 172 | 85 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 172 | 57 |
| Lisinopril | Lisinopril | 168 | 53 |
| Tamsulosin Hcl | Tamsulosin Hcl | 168 | 57 |
| Famotidine | Famotidine | 157 | 58 |
| Hydralazine Hcl | Hydralazine Hcl | 155 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 154 | 69 |
| Doxycycline Hyclate | Doxycycline Hyclate | 147 | 108 |
| Glipizide Er | Glipizide | 145 | 46 |
| Furosemide | Furosemide | 142 | 47 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 138 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 132 | 34 |
| Simvastatin | Simvastatin | 121 | 36 |
| Tramadol Hcl | Tramadol Hcl | 108 | 33 |
| Trazodone Hcl | Trazodone Hcl | 108 | 42 |
| Eliquis | Apixaban | 107 | 24 |
| Ozempic | Semaglutide | 103 | 19 |
| Rybelsus | Semaglutide | 101 | 22 |
| Metoprolol Tartrate | Metoprolol Tartrate | 98 | 32 |
| Clonazepam | Clonazepam | 96 | 17 |
| Sertraline Hcl | Sertraline Hcl | 93 | 26 |
| Montelukast Sodium | Montelukast Sodium | 89 | 29 |
| Januvia | Sitagliptin Phosphate | 84 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 83 | 29 |
| Ezetimibe | Ezetimibe | 81 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 81 | 37 |
| Allopurinol | Allopurinol | 79 | 26 |
| Meloxicam | Meloxicam | 79 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 77 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 75 | 25 |
| Methylprednisolone | Methylprednisolone | 69 | 55 |
| Spironolactone | Spironolactone | 65 | 19 |
| Alendronate Sodium | Alendronate Sodium | 64 | 18 |
| Alprazolam | Alprazolam | 64 | suppressed |
| Nifedipine Er | Nifedipine | 62 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 61 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | 19 |
| Metformin Hcl Er | Metformin Hcl | 58 | 17 |
| Carvedilol | Carvedilol | 54 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 54 | 27 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 33 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 41 |
| Azelastine Hcl | Azelastine Hcl | 44 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 44 | 13 |
| Torsemide | Torsemide | 44 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 43 | suppressed |
| Telmisartan | Telmisartan | 43 | 15 |
| Finasteride | Finasteride | 42 | 13 |
| Mupirocin | Mupirocin | 41 | 23 |
| Breo Ellipta | Fluticasone/Vilanterol | 39 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 12 |
| Pregabalin | Pregabalin | 39 | 14 |
| Jardiance | Empagliflozin | 37 | 14 |
| Methocarbamol | Methocarbamol | 36 | 14 |
| Sucralfate | Sucralfate | 36 | 12 |
| Donepezil Hcl | Donepezil Hcl | 35 | 13 |
| Spiriva Respimat | Tiotropium Bromide | 35 | 11 |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | 11 |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 33 | 11 |
| Nystatin | Nystatin | 32 | 18 |
| Promethazine Hcl | Promethazine Hcl | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 14 |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 31 | 23 |
| Prednisone | Prednisone | 31 | 13 |
| Temazepam | Temazepam | 31 | suppressed |
| Silodosin | Silodosin | 30 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 30 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 30 | 18 |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Mounjaro | Tirzepatide | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | 12 |
| Levofloxacin | Levofloxacin | 25 | 20 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 25 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 24 | 23 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Celecoxib | Celecoxib | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Livalo | Pitavastatin Calcium | 20 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Lidocaine | Lidocaine | 18 | suppressed |
| Myrbetriq | Mirabegron | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 18 | suppressed |
| Clonidine | Clonidine | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 13 |
| Irbesartan | Irbesartan | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Xarelto | Rivaroxaban | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 15 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 15 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Lactulose | Lactulose | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 15 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Ciclopirox | Ciclopirox | 13 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Probenecid-Colchicine | Probenecid/Colchicine | 13 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 13 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 13 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 13 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Rexulti | Brexpiprazole | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Azithromycin | Azithromycin | 11 | 11 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $124.32 · 1 records | Axsome Therapeutics, Inc. | Auvelity | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error